Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years | Zendy

Sharon Nachman | Zendy; Naiyu Zheng | Zendy; Edward P. Acosta | Zendy; Hedy Teppler | Zendy; Brenda Homony | Zendy; Bobbie Graham | Zendy; T. Fenton | Zendy; Xin Xu | Zendy; Larissa Wenning | Zendy; Stephen A. Spector | Zendy; Lisa M. Frenkel | Zendy; C. Alvero | Zendy; C. Worrell | Zendy; Edward Handelsman | Zendy; Andrew Wiznia | Zendy; Harry Moultrie | Zendy; G. Kindra | Zendy; Margaret Ann Sanders | Zendy; Ruth Williams | Zendy; Jennifer Jensen | Zendy; Mónica Acevedo | Zendy; L. Fabregas | Zendy; Andrea Jurgrau | Zendy; Marc Foca | Zendy; Abigail Higgins | Zendy; Jaime Deville | Zendy; Karin NielsenSaines | Zendy; Michele Carter | Zendy; John Swetnam | Zendy; Joan Wilson | Zendy; Michael Donnelly | Zendy; S. Akleh | Zendy; M. Rigaud | Zendy; Aditya Kaul | Zendy; Naomi J. Patel | Zendy; Ashok Gaur | Zendy; L. J. Utech | Zendy; Evelina Cardoso | Zendy; Airton Mota Moreira | Zendy; Breno Santos | Zendy; Raziya Bobat | Zendy; R. Mngqibisa | Zendy; Marlene Burey | Zendy; Jacobo Abadi | Zendy; Mark E. Rosenberg | Zendy; Katherine Luzuriaga | Zendy; D. Picard | Zendy; Jesica PaganoTherrien | Zendy; S. Dittmer | Zendy; H. N. Ndiweni | Zendy; Ankit Patel | Zendy; M. DelRey | Zendy; C. McMullen-Jackson | Zendy; Mary E. Paul | Zendy; Ann J. Melvin | Zendy; Corry Venema-Weiss | Zendy; James R. Lane | Zendy; Christy Beneri | Zendy; D. Ferraro | Zendy; E. Infanzon | Zendy; James McAuley | Zendy; Majid Aziz | Zendy; Maureen F. McNichols | Zendy; Stephen I. Pelton | Zendy; Debra McLaud | Zendy; Diana F. Clarke | Zendy; Steven L. Zeichner | Zendy; Ayşegül Akar | Zendy; Debrah M. Thompson | Zendy; Steven D. Douglas | Zendy; Richard M. Rutstein | Zendy; Carol Ann Vincent | Zendy; Mary E. Vachon | Zendy; Michele Alessandro Cavallo | Zendy; Murli Purswani | Zendy; Gaerolwe Masheto | Zendy; Anthony Ogwu | Zendy; Tebogo J. Kakhu | Zendy; Rolando M. Viani | Zendy; A. Darcey | Zendy; Kimberley Norris | Zendy; Sandra Burchett | Zendy; Catherine Kneut | Zendy; Nancy Karthas | Zendy; D Casey | Zendy; Patricia Emmanuel | Zendy; Jorge LujánZilbermann | Zendy; Sohail Rana | Zendy; Patricia Houston | Zendy; Mulu Mengistab | Zendy; Mobeen H. Rathore | Zendy; Ayesha Mirza | Zendy; Tabetha Lynn Gayton | Zendy; Emily Barr | Zendy; Jennifer Dunn | Zendy; Kristine Hahn | Zendy; Zulma Eysallenne | Zendy; FM Howard | Zendy; Kathryn Graham | Zendy; Marinella Della Negra | Zendy; Wladimir Queiroz | Zendy; Yonghong Lian | Zendy; D. W. Wara | Zendy; Theodore Ruel | Zendy; Rhonda VanDyke | Zendy; Paul A. Reilly | Zendy; Sarah Bradford | Zendy; A. J. Van Rensburg | Zendy; Els Dobbels | Zendy; Maxim Bester | Zendy; Mahrukh Bamji | Zendy; Steven M. Paul | Zendy; Mirala Sarza | Zendy; Andrea Kovacs | Zendy; James Homans | Zendy; LaShonda Spencer | Zendy; Cristina Barroso Hofer | Zendy; Thalita Fernandes de Abreu | Zendy; Rhaul Oliveira | Zendy; Esaú João | Zendy; Jorge Pinto | Zendy; Frederico Castelo Ferreira | Zendy; Fabiana Maria Kakehasi | Zendy; Maria Célia Cervi | Zendy; M. D. L. Isaac | Zendy; M Losso | Zendy; Erica Stankievich | Zendy; Irene Foradori | Zendy; David Tucker | Zendy; Jarrod E. Church | Zendy; Marvin Belzer | Zendy; James Hopkins | Zendy; Jonathan M. Ellen | Zendy; Allison L. Agwu | Zendy; B. Laurel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years

Author(s) -

Sharon Nachman,

Naiyu Zheng,

Edward P. Acosta,

Hedy Teppler,

Brenda Homony,

Bobbie Graham,

T. Fenton,

Xin Xu,

Larissa Wenning,

Stephen A. Spector,

Lisa M. Frenkel,

C. Alvero,

C. Worrell,

Edward Handelsman,

Andrew Wiznia,

Harry Moultrie,

G. Kindra,

Margaret Ann Sanders,

Ruth Williams,

Jennifer Jensen,

Mónica Acevedo,

L. Fabregas,

Andrea Jurgrau,

Marc Foca,

Abigail Higgins,

Jaime Deville,

Karin NielsenSaines,

Michele Carter,

John Swetnam,

Joan Wilson,

Michael Donnelly,

S. Akleh,

M. Rigaud,

Aditya Kaul,

Naomi J. Patel,

Ashok Gaur,

L. J. Utech,

Evelina Cardoso,

Airton Mota Moreira,

Breno Santos,

Raziya Bobat,

R. Mngqibisa,

Marlene Burey,

Jacobo Abadi,

Mark E. Rosenberg,

Katherine Luzuriaga,

D. Picard,

Jesica PaganoTherrien,

S. Dittmer,

H. N. Ndiweni,

Ankit Patel,

M. DelRey,

C. McMullen-Jackson,

Mary E. Paul,

Ann J. Melvin,

Corry Venema-Weiss,

James R. Lane,

Christy Beneri,

D. Ferraro,

E. Infanzon,

James McAuley,

Majid Aziz,

Maureen F. McNichols,

Stephen I. Pelton,

Debra McLaud,

Diana F. Clarke,

Steven L. Zeichner,

Ayşegül Akar,

Debrah M. Thompson,

Steven D. Douglas,

Richard M. Rutstein,

Carol Ann Vincent,

Mary E. Vachon,

Michele Alessandro Cavallo,

Murli Purswani,

Gaerolwe Masheto,

Anthony Ogwu,

Tebogo J. Kakhu,

Rolando M. Viani,

A. Darcey,

Kimberley Norris,

Sandra Burchett,

Catherine Kneut,

Nancy Karthas,

D Casey,

Patricia Emmanuel,

Jorge LujánZilbermann,

Sohail Rana,

Patricia Houston,

Mulu Mengistab,

Mobeen H. Rathore,

Ayesha Mirza,

Tabetha Lynn Gayton,

Emily Barr,

Jennifer Dunn,

Kristine Hahn,

Zulma Eysallenne,

FM Howard,

Kathryn Graham,

Marinella Della Negra,

Wladimir Queiroz,

Yonghong Lian,

D. W. Wara,

Theodore Ruel,

Rhonda VanDyke,

Paul A. Reilly,

Sarah Bradford,

A. J. Van Rensburg,

Els Dobbels,

Maxim Bester,

Mahrukh Bamji,

Steven M. Paul,

Mirala Sarza,

Andrea Kovacs,

James Homans,

LaShonda Spencer,

Cristina Barroso Hofer,

Thalita Fernandes de Abreu,

Rhaul Oliveira,

Esaú João,

Jorge Pinto,

Frederico Castelo Ferreira,

Fabiana Maria Kakehasi,

Maria Célia Cervi,

M. D. L. Isaac,

M Losso,

Erica Stankievich,

Irene Foradori,

David Tucker,

Jarrod E. Church,

Marvin Belzer,

James Hopkins,

Jonathan M. Ellen,

Allison L. Agwu,

B. Laurel

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit696

Subject(s) - medicine , raltegravir , pharmacokinetics , rash , tolerability , adverse effect , cmax , cohort , pharmacology , viral load , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy

IMPAACT P1066 is a phase I/II open-label multicenter trial to evaluate pharmacokinetics, safety, tolerability, and efficacy of multiple raltegravir formulations in human immunodeficiency virus (HIV)-infected youth.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research